Coromandel International
Coromandel International
ChemicalsKey Fundamentals
MidcapFertilizersChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Growth Rate
AI Analysis — Bull vs Bear
Coromandel International, with a market cap of ₹56,684 Cr, is a large-cap chemicals/fertilizer company trading at a PE of 32.6x and PB of 4.61x. TTM sales growth is strong at 24%, but TTM profit has declined 6%, and the stock has corrected 12% over the past year after delivering a 10-year stock CAGR of 23%.
- Strong TTM revenue growth of 24% indicates robust demand and improving top-line momentum
- Impressive long-term wealth creation with 10-year stock CAGR of 23% and 5-year CAGR of 19%
- Healthy long-term profitability with 10-year compounded profit growth of 19%
- Consistent return ratios with 5-year average ROE of 20% and 10-year average ROE of 22%, reflecting efficient capital deployment
- 5-year compounded sales growth of 17% demonstrates sustained business expansion across cycles
- Large-cap scale at ₹56,684 Cr market cap provides liquidity, institutional interest, and competitive moat in the fertilizer segment
- 5-year compounded profit growth of 8% shows the company has maintained profitability even through volatile input cost environments
- TTM profit declined 6% despite 24% revenue growth, signaling margin compression and rising input costs
- 3-year compounded profit growth is negative at -1%, indicating earnings stagnation over a meaningful period
- Stock has corrected 12% over the past 1 year, underperforming broader markets and reflecting weakening sentiment
- PE of 32.6x is elevated for a fertilizer/chemicals business, leaving limited margin of safety if earnings disappoint further
- ROE has declined from 22% (10-year) to 16% (last year), a notable deterioration in return on equity
- 3-year compounded sales growth of only 2% suggests the recent 24% TTM surge may not be sustainable
- Dividend yield of just 0.56% offers minimal income cushion for investors during periods of capital depreciation
- PB ratio of 4.61x indicates the stock is priced at a significant premium to book value, which may limit upside
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- GST penalty ₹12.35 lakh Aug 21
Coromandel received a ₹12.35 lakh GST penalty order from Jammu Commissionerate on Aug 20, related to FY2018-19 ITC mismatch. The company has filed an appeal.
- Dhaksha opens drone plant Aug 24
Subsidiary Dhaksha Unmanned Systems inaugurated a new manufacturing facility in Kancheepuram, targeting agriculture and defence drone capabilities.
TL;DR: Coromandel is diversifying beyond chemicals with its drone subsidiary Dhaksha opening a new manufacturing plant, signaling growth ambitions in agriculture-tech and defence. The GST penalty of ₹12.35 lakh is financially immaterial for a company of this size and is being appealed. Overall, the news flow is mildly positive with no significant operational or sectoral headwinds emerging.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 | 9,654 | 8,779 | 6,004 | 8,165 |
| Expenses | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 | 8,508 | 7,980 | 5,516 | 7,409 |
| Operating Profit | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 | 1,147 | 800 | 488 | 756 |
| OPM % | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% | 12% | 9% | 8% | 9% |
| Other Income | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 | 116 | 83 | -6 | 50 |
| Interest | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 | 102 | 84 | 89 | 89 |
| Depreciation | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 | 102 | 147 | 165 | 203 |
| PBT | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 | 1,059 | 653 | 228 | 514 |
| Tax % | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% | 25% | 25% | 50% | 26% |
| Net Profit | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 | 793 | 488 | 115 | 382 |
| EPS in Rs | 16.8 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 | 27.31 | 17.15 | 4.74 | 12.91 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 31,480 | 32,602 |
| Expenses | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 28,248 | 29,412 |
| Operating Profit | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,232 | 3,190 |
| OPM % | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 10% | 10% |
| Other Income | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 262 | 243 |
| Interest | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 343 | 364 |
| Depreciation | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 534 | 616 |
| PBT | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 2,617 | 2,454 |
| Tax % | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | 27% | — |
| Net Profit | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 1,898 | 1,778 |
| EPS in Rs | 13.8 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.3 | 52.08 | 68.46 | 55.78 | 70.14 | 66.31 | 62.11 |
| Div. Payout % | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% | 3% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 |
| Reserves | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,528 |
| Borrowings | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,506 |
| Other Liabilities | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 10,397 |
| Total Liabilities | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,461 |
| Fixed Assets | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 6,737 |
| CWIP | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 348 |
| Investments | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 2,044 |
| Other Assets | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,331 |
| Total Assets | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,461 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 86 | 18 | 915 | 263 | 526 | 1,862 | 4,150 | 2,078 | 591 | 1,428 | 2,464 | 1,558 |
| Investing | -216 | -61 | -79 | 38 | -597 | -220 | -1,245 | -1,622 | 640 | -1,333 | -2,638 | -559 |
| Financing | -64 | 8 | -864 | -1 | -244 | -1,723 | -2,263 | -443 | -543 | -363 | -698 | -831 |
| Net Cash Flow | -194 | -34 | -28 | 300 | -314 | -82 | 642 | 14 | 688 | -269 | -872 | 168 |
| Free Cash Flow | -6 | -89 | 834 | 134 | 255 | 1,606 | 3,958 | 1,801 | 22 | 910 | 2,030 | 22 |
| CFO/OP | 27 | 25 | 120 | 49 | 62 | 128 | 232 | 119 | 45 | 86 | 123 | 71 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 | 24 |
| Inventory Days | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 | 111 |
| Days Payable | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 119 | 123 | 136 |
| Cash Conversion Cycle | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 6 | -7 | -1 |
| Working Capital Days | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 46 | 28 | 35 |
| ROCE % | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% | 22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Coromandel International insights
65 extracted metrics + investor summaries across FY12–FY27.
Documents
Frequently Asked Questions about Coromandel International
What does Coromandel International Ltd do?
Where is Coromandel International Ltd (COROMANDEL) listed?
Which sector does Coromandel International Ltd belong to?
What is the market capitalisation of Coromandel International Ltd?
What is the PE ratio of Coromandel International Ltd?
What is the 52-week high and low of Coromandel International Ltd?
Does Coromandel International Ltd pay dividends?
What is the Return on Equity (ROE) of Coromandel International Ltd?
Company Information
Business Segments [1] a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: [2] [3] [4] [5] It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest private-sector NPK player, and a pioneering leader in the Nano DAP segment. It also holds a 35% share in the unique products segment and a 17.5% market share on a consumption basis. ii) Specialty Nutrients: [4] [3] The company is the pioneer & market leader in India's specialty nutrients segment, offering water-soluble fertilizers, secondary and micronutrients, and nano fertilizer products. iii) Organic Fertilizers: [6] [3] The company markets organic fertilizers, producing a range of products derived from natural sources such as city waste, sugarcane molasses and its by-products, oil cakes, and gypsum. b) Crop Protection (12% in FY26 vs 10% in FY25):: i) Crop Protection: [7] [8] [3] The company manufactures and markets a range of insecticides, fungicides, herbicides, plant growth regulators, technicals and formulations in India and international markets. It is the country's 4th-largest agrochemical player by value, with the capability to manufacture 20 technicals and intermediates. It is also the 2nd-largest manufacturer of Malathion globally and a major manufacturer of Phenthoate in Asia. ii) Bio Products: [4] [9] [10] Bio Products business focuses on plant-based extracts for agricultural applications, offering a comprehensive portfolio of biopesticides based on Azadirachtin, plant-derived biostimulants, anti-transpirants and non-ionic spreaders. It holds a global leadership position in the Azadirachtin market, with a presence across more than 40 countries in the Americas, Europe and Asia. Sale Volumes (in Lakh MT):[11] NPK+DAP: 42.77 in FY26 vs 39.88 in FY25 SSP: 8.41 in FY26 vs 7.73 in FY25 MOP: 0.67 in FY26 vs 0.69 in FY25 Urea: 22.65 in FY26 vs 13.59 in FY25 Geographical Split[12] Domestic: 94% in FY26 vs 95% in FY25 Exports: 6% in FY26 vs 5% in FY25 Retail Presence[13] [4] [14] The company operates India's largest agri-retail network with over 1,200 agri-retail outlets across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu and Maharashtra. It is supported by over 3,000 marketing professionals and serves more than 5 Mn farmers across its operating markets. It has a network of 12,000 channel partners. New Product Launches[15] In FY26, Coromandel expanded its portfolio with new launches across Specialty Nutrients, Crop Protection and Bio Products. It's key additions included Fertinex 28:28:0, GypMax, Novonese, Organovita and Summit in Specialty Nutrients; Daliso, Ghibli, Chhaava and Invicto in Crop Protection; and CoroBT, GroBT, Coroscens, CoroShakti and other biological solutions to strengthen its bio-products portfolio. Manufacturing Capabilities[4] [16] The company operates 21 manufacturing facilities across India, with a total capacity of: Fertilizers: 3.5 Mn MT SSP: 1 Mn MT Specialty Nutrients: 87,500 MT Nano Fertilizers: 10,000 KL Crop Protection Chemicals: 0.87 Lakh MT Bio Products: 22.5 MT Expansion & Backward Integration[17] [18] The company commissioned a 2,000 TPD sulphuric acid plant and a 650 TPD phosphoric acid plant at Kakinada in Q4 FY26, for Rs. 1,100 Cr. It also advanced construction of the 7.5 lakh TPA NPK granulation Train H at Kakinada, expected to increase the site's total fertilizer capacity to 30 lakh TPAby Q4 FY27. Additionally, its Senegal rock phosphate project, where the company holds a 53.8% stake, commissioned a fixed processing plant and ramped up production to secure raw material supplies for the Kakinada phosphoric acid facility. It also added a 9 KTPA technical plant at Dahej for off-patent fungicides, along with capacity additions for key technical molecules at Ankleshwar and a herbicide block expansion at Sarigam. Acquisitions[19] [17] In Aug 2025, the company acquired a 53.13% controlling stake in NACL Industries for Rs. 820 Cr. MoU[20] In Nov 2025, the company signed a non-binding MoU with the Andhra Pradesh Economic Development Board to explore investments of up to Rs. 2,000 Cr in Andhra Pradesh. Focus[21] The company expects a 20-25% revenue growth in the crop protection business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COROMANDEL.md for Coromandel International Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.